Perimenopause and menopause are natural stages in a woman’s life, yet they are still surrounded by confusion and many questions. At Praxis Clinic, we see women every day wondering whether their symptoms could be related to hormones: fatigue, irritability, anxiety, disrupted sleep, irregular menstrual cycles, and/or heavier bleeding. Often, the first signs appear much earlier than expected.

For many women, the very first signs of perimenopause do not appear as changes in the menstrual cycle. They usually occur during the luteal phase, which follows ovulation—1 to 2 weeks before the period. This is when many notice more intense premenstrual symptoms, different from what they have experienced before: unusual irritability, emotional sensitivity, increased anxiety, tender breasts, headaches, cravings, and more fragile sleep. These variations often reflect a more significant drop in progesterone, a key hormone for calmness, sleep, and emotional stability. Many women then feel “less tolerant,” more easily overwhelmed, or experience a mental fog they have never encountered before. These signs sometimes appear months, or even years, before the first menstrual irregularities.

When cycles begin to change, they may become shorter or longer, heavier, more painful, or occur at unusual intervals. These variations are rarely dangerous; they simply reflect ovarian activity becoming less consistent. Perimenopause is not a sudden stop in ovarian function, but rather a gradual transition during which hormones fluctuate before a permanent decline. This period is often compared to a rollercoaster.

At this time, other common symptoms often appear as well; hot flashes and night sweats, for example, result from increased sensitivity of the brain’s thermoregulatory center to hormonal fluctuations. Some women experience them rarely, others daily, and sometimes triggers include caffeine, alcohol, chocolate, sugar, heat, stress, or large meals. Although disruptive and uncomfortable, these symptoms can be managed.

Sleep often becomes more fragile, marked by frequent awakenings, insomnia, or mental restlessness. This is influenced not only by hormonal changes but also by the mental load typical of this stage of life. Women wonder why they no longer experience restorative sleep as before. The answer is hormonal, but also emotional, physiological, and contextual. A comprehensive approach—including sleep hygiene, regular physical activity, stress management, and hormonal support when necessary—can help restore more satisfying and restorative sleep.

One of the most frustrating issues is weight gain or changes in body composition without changes in diet or physical activity. The gradual decline of estrogen and increase in other key hormones affect how the body stores fat, particularly around the abdomen. Metabolism changes, insulin sensitivity fluctuates, and less stable sleep all play a role in appetite, cravings, and energy management. This is not a matter of willpower but a combination of physiological changes that require a new strategy based on lifestyle adjustments such as strength training, balanced nutrition, stress management, and adequate sleep.

Sexual health also evolves. Libido may decrease, fluctuate, disappear, or sometimes even increase. Vaginal dryness or pain during intercourse is common due to reduced local estrogen. This does not mean sexual life must deteriorate or stop. Simple and effective solutions are available, from lubricants to vaginal treatments, as well as more comprehensive hormonal approaches.

Many women also wonder whether they should have blood tests to “confirm” perimenopause. Blood tests can be useful when combined with symptom management to achieve better balance and evaluate treatment response. It is important to understand that hormone levels vary within the same cycle, and a single blood test only reflects levels at the time of sampling. Clinical evaluation and symptom assessment remain the most reliable tools used by hormonal health experts. That said, a comprehensive metabolic, preventive, and hormonal assessment can be valuable in managing various symptoms.

Hormone therapy raises many questions. Current scientific data are reassuring: when used at the right time, in the correct dose, and in bioidentical form, it is one of the most effective treatments for reducing and improving moderate to severe symptoms. Additionally, it contributes to preventive health for bone density, cardiovascular and brain health, and significantly improves quality of life. Every woman should be evaluated individually by a professional to choose the safest and most beneficial option.

Perimenopause and menopause are physiological transitions that deserve to be understood and supported by professionals who have up-to-date, science-based knowledge. These are life stages in which women need attentive listening and personalized follow-up. At Praxis, our mission is to provide women with a space where they can be heard, understood, and supported as their bodies navigate these periods, often experienced as isolating and stigmatizing.

References

Baber, R. J., Panay, N., & Fenton, A. (2022). 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002004

Black, A., & Légaré, F. (2021). Lignes directrices canadiennes sur la ménopause : Mise à jour 2021. Société des obstétriciens et gynécologues du Canada (SOGC). https://sogc.org

Bluming, A., & Tavris, C. (2018). Estrogen Matters: Why Taking Hormones in Menopause Can Improve Women’s Well-Being and Lengthen Their Lives — Without Raising the Risk of Breast Cancer. Little, Brown Spark.

Cartier, R., & Birkhäuser, M. (2023). Comprendre et traiter la ménopause aujourd’hui. Revue médicale suisse, 19(833–834), 2052–2060.

Demers, S. (2008). Hormones au féminin : Guide d’hormonothérapie bio-identique. Éditions Béliveau.

Demers, S. (2010). Cholestérol et hormones : Mythes, controverses et réalité scientifique. Éditions Béliveau.

Desautels, L. (2019). Mieux vivre la ménopause. Éditions La Presse.

Faubion, S. S., Larkin, L. C., Stuenkel, C. A., Bachmann, G. A., & Kaunitz, A. M. (2022). Management of genitourinary syndrome of menopause in women: A clinical consensus statement from The North American Menopause Society. Menopause, 29(12), 1402–1417. https://doi.org/10.1097/GME.0000000000002071

Gava, G., Gualdi, C., Tagliasacchi, D., & Seracchioli, R. (2023). Perimenopause: Clinical manifestations and diagnosis. New England Journal of Medicine, 389(3), 209–220. https://doi.org/10.1056/NEJMra2203638

Gu, Y., Han, F., Xue, M., Wang, M., & Huang, Y. (2024). The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: A systematic review and meta-analysis. BMC Women’s Health, 24, Article 60. https://doi.org/10.1186/s12905-023-02788-0

Haver, M. C. (2024). The New Menopause: Navigating Your Path Through Midlife with More Ease and Less Stress. Penguin Random House.

INESSS. (2023). Hormonothérapie ménopausique : efficacité, sécurité et considérations cliniques. Institut national d’excellence en santé et en services sociaux. https://www.inesss.qc.ca

INESSS. (2024). Outil d’aide à la décision clinique : Prise en charge des symptômes de la ménopause en première ligne. Institut national d’excellence en santé et en services sociaux. https://www.inesss.qc.ca

Kanaya, A. M., et al. (2024). Evidence-based management of menopause. JAMA, 331(5), 442–453. https://doi.org/10.1001/jama.2024.0152

Kim, M. J., & Lee, S. R. (2020). The 2020 Menopausal Hormone Therapy Guidelines. Obstetrics & Gynecology Science, 63(4), 303–324. https://doi.org/10.5468/ogs.2020.63.4.303

Manson, J. E., & Kaunitz, A. M. (2022). Rethinking menopausal hormone therapy: For whom, what, when. Circulation, 146(13), 1003–1015. https://doi.org/10.1161/CIRCULATIONAHA.122.061559

National Institute for Health and Care Excellence (NICE). (2023). Menopause: Diagnosis and management (NG23). https://www.nice.org.uk/guidance/ng23

OIIQ. (2022). Prise en charge de la santé des femmes en période de transition ménopausique : repères cliniques pour la pratique infirmière avancée. Ordre des infirmières et infirmiers du Québec. https://www.oiiq.org

Prescrire. (2022). Traitements hormonaux de la ménopause : bénéfices, limites et surveillance. Prescrire. https://www.prescrire.org

Stuenkel, C. A., et al. (2021). Treatment of symptoms of the menopause: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 106(11), e3933–e3995. https://doi.org/10.1210/clinem/dgab451

The North American Menopause Society (NAMS). (2023). Nonhormonal management of menopause-associated vasomotor symptoms: 2023 position statement. Menopause, 30(4), 448–475. https://doi.org/10.1097/GME.0000000000002150

Lincey Bernier IPSPL Clinique Praxis St-Sauveur